Home » Delcath Axes One-Fifth of Workforce
Delcath Axes One-Fifth of Workforce
Delcath has decided to fire a fifth of its employees after receiving a negative FDA review for its Melblez device to treat metastasized eye cancer.
Qmed
Qmed
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May